Crop Life Science Share Price
Sector:
49.00 0.00 (0.00%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
49.00
Today’s High
49.00
52 Week Low
37.55
52 Week High
69.20
Key Metrics
- Market Cap (In Cr) 83.99
- Beta -
- Div. Yield (%) 0
- P/B 1.17
- TTM P/E 13.76
- Sector P/E 17.34
- D/E 0.01
Crop Life Science Analysis
Price Analysis
-
1 Week-3.83%
-
3 Months0.2%
-
6 Month2.08%
-
YTD-2.29%
-
1 Year19.51%
Crop Life Science News
Crop Life Science lists with 7.6% premium at ₹55.95 per share on NSE Emerge
1 min read . 30 Aug 2023Crop Life Science IPO: What does the latest GMP signal ahead of listing?
2 min read . 29 Aug 2023IPOs Next Week: Rishabh Instruments IPO, 3 other issues to open; check details
4 min read . 03 Sep 2023Crop Life Science IPO allotment finalised: here's how to check allotment status
3 min read . 25 Aug 2023Crop Life Science Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 198.61
- Selling/ General/ Admin Expenses Total
- 11.26
- Depreciation/ Amortization
- 3.23
- Other Operating Expenses Total
- 28.47
- Total Operating Expense
- 189.22
- Operating Income
- 9.39
- Net Income Before Taxes
- 8.11
- Net Income
- 6.02
- Diluted Normalized EPS
- 3.29
- Period
- 2024
- Total Assets
- 179.87
- Total Liabilities
- 108.14
- Total Equity
- 71.73
- Tangible Book Valueper Share Common Eq
- 40.22
- Period
- 2024
- Cashfrom Operating Activities
- -8.33
- Cashfrom Investing Activities
- -3.42
- Cashfrom Financing Activities
- 13.43
- Net Changein Cash
- 1.67
- Period
- 2023
- Total Revenue
- 131.23
- Selling/ General/ Admin Expenses Total
- 11.29
- Depreciation/ Amortization
- 3.71
- Other Operating Expenses Total
- 15.96
- Total Operating Expense
- 123.16
- Operating Income
- 8.07
- Net Income Before Taxes
- 5.6
- Net Income
- 4.07
- Diluted Normalized EPS
- 3.39
- Period
- 2023
- Total Assets
- 101.59
- Total Liabilities
- 61.03
- Total Equity
- 40.55
- Tangible Book Valueper Share Common Eq
- 33.51
- Period
- 2023
- Cashfrom Operating Activities
- 2.27
- Cashfrom Investing Activities
- -4.48
- Cashfrom Financing Activities
- 0.52
- Net Changein Cash
- -1.69
- Period
- 2022
- Total Revenue
- 102.01
- Selling/ General/ Admin Expenses Total
- 10.88
- Depreciation/ Amortization
- 2.25
- Other Operating Expenses Total
- 23.98
- Total Operating Expense
- 96.55
- Operating Income
- 5.46
- Net Income Before Taxes
- 3.77
- Net Income
- 2.81
- Diluted Normalized EPS
- 1.62
- Period
- 2022
- Total Assets
- 94.58
- Total Liabilities
- 58.56
- Total Equity
- 36.02
- Tangible Book Valueper Share Common Eq
- 20.8
- Period
- 2022
- Cashfrom Operating Activities
- -0.15
- Cashfrom Investing Activities
- -1.99
- Cashfrom Financing Activities
- 1.11
- Net Changein Cash
- -1.02
- Period
- 2021
- Total Revenue
- 118.93
- Selling/ General/ Admin Expenses Total
- 11.06
- Depreciation/ Amortization
- 2.52
- Other Operating Expenses Total
- 31.57
- Total Operating Expense
- 112.71
- Operating Income
- 6.22
- Net Income Before Taxes
- 4.93
- Net Income
- 3.7
- Diluted Normalized EPS
- 2.14
- Period
- 2021
- Total Assets
- 86.3
- Total Liabilities
- 53.15
- Total Equity
- 33.15
- Tangible Book Valueper Share Common Eq
- 19.08
- Period
- 2021
- Cashfrom Operating Activities
- 3.5
- Cashfrom Investing Activities
- -2.15
- Cashfrom Financing Activities
- -0.57
- Net Changein Cash
- 0.78
- Period
- 2020
- Total Revenue
- 135.13
- Selling/ General/ Admin Expenses Total
- 9.84
- Depreciation/ Amortization
- 1.75
- Other Operating Expenses Total
- 26.34
- Total Operating Expense
- 128.61
- Operating Income
- 6.52
- Net Income Before Taxes
- 4.59
- Net Income
- 3.23
- Diluted Normalized EPS
- 1.88
- Period
- 2020
- Total Assets
- 76.45
- Total Liabilities
- 46.75
- Total Equity
- 29.7
- Tangible Book Valueper Share Common Eq
- 17
- Period
- 2020
- Cashfrom Operating Activities
- 2.51
- Cashfrom Investing Activities
- -0.74
- Cashfrom Financing Activities
- -2.52
- Net Changein Cash
- -0.75
- Period
- 2024-09-30
- Total Revenue
- 106.33
- Selling/ General/ Admin Expenses Total
- 5.7
- Depreciation/ Amortization
- 2.35
- Other Operating Expenses Total
- 13.17
- Total Operating Expense
- 100.28
- Operating Income
- 6.04
- Net Income Before Taxes
- 3.79
- Net Income
- 2.77
- Diluted Normalized EPS
- 2.21
- Period
- 2024-09-30
- Total Assets
- 234.7
- Total Liabilities
- 159.83
- Total Equity
- 74.87
- Tangible Book Valueper Share Common Eq
- 43.26
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -6.37
- Cashfrom Investing Activities
- -1.05
- Cashfrom Financing Activities
- 6.35
- Net Changein Cash
- -1.08
- Period
- 2024-03-31
- Total Revenue
- 101.16
- Selling/ General/ Admin Expenses Total
- 5.82
- Depreciation/ Amortization
- 1.54
- Other Operating Expenses Total
- 14.01
- Total Operating Expense
- 96.51
- Operating Income
- 4.65
- Net Income Before Taxes
- 3.93
- Net Income
- 2.66
- Diluted Normalized EPS
- 1.55
- Period
- 2024-03-31
- Total Assets
- 179.87
- Total Liabilities
- 108.14
- Total Equity
- 71.73
- Tangible Book Valueper Share Common Eq
- 40.22
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -8.33
- Cashfrom Investing Activities
- -3.42
- Cashfrom Financing Activities
- 13.43
- Net Changein Cash
- 1.67
- Period
- 2023-09-30
- Total Revenue
- 97.45
- Selling/ General/ Admin Expenses Total
- 5.44
- Depreciation/ Amortization
- 1.68
- Other Operating Expenses Total
- 14.46
- Total Operating Expense
- 92.7
- Operating Income
- 4.74
- Net Income Before Taxes
- 4.17
- Net Income
- 3.36
- Diluted Normalized EPS
- 2.61
- Period
- 2023-09-30
- Total Assets
- 180.58
- Total Liabilities
- 111.2
- Total Equity
- 69.38
- Tangible Book Valueper Share Common Eq
- 40.29
- Period
- 2023-09-30
- Cashfrom Operating Activities
- -17.63
- Cashfrom Investing Activities
- -0.06
- Cashfrom Financing Activities
- 19.77
- Net Changein Cash
- 2.08
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Crop Life Science Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Supreme Facility Management
- 35.05
- -0.7
- -1.96
- 75
- 27.4
- 87.03
- Forge Auto International
- 77
- -1
- -1.28
- 115
- 60
- 84.08
- Crop Life Science
- 49
- 0
- 0
- 69.2
- 37.55
- 83.99
- Presstonic Engineering
- 108.9
- 1.55
- 1.44
- 180.5
- 80.35
- 83.93
- Picturepost Studios
- 28.1
- 0
- 0
- 45.6
- 24.9
- 82.33
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Supreme Facility Management
- 12.21
- 2.55
- -
- -
- Forge Auto International
- 13.51
- 4.09
- -
- -
- Crop Life Science
- 14.88
- 1.17
- -
- -
- Presstonic Engineering
- 22.95
- 3.33
- -
- -
- Picturepost Studios
- 23.96
- 9.59
- -
- -
Crop Life Science Shareholding
Shareholding Pattern
*Promoter pledging: 1.46%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 01-Apr-25
- Others
- 27-Feb-25
- Others
- 14-Nov-24
- Quarterly Results
- 27-May-24
- Audited Results
- Meeting Date
- Announced on
- Purpose
- 21-Sept-24
- 04-Aug-24
- AGM
- 13-Dec-23
- 28-Aug-23
- AGM



